Income Statement

v3.10.0.1
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenues $ 252,500 $ 2,500 $ 255,000 $ 5,000
Operating expenses:        
Research and development expenses 1,014,780 2,585,079 2,184,221 5,487,165
General and administrative expenses 1,260,692 1,635,652 2,442,746 2,968,073
Total operating expenses 2,275,472 4,220,731 4,626,967 8,455,238
Operating loss (2,022,972) (4,218,231) (4,371,967) (8,450,238)
Other income (expense):        
Interest income 19,514 14,013 37,263 34,896
Interest expense (772) (15,728) (2,692) (154,460)
Change in fair value of derivative instruments 1,378,830 (341,611) 1,569,049 (3,082,925)
Fees related to issuance of indcuement warrants and other expenses (1,646) (87,635) (5,667) (563,719)
Total other income (expense) 1,395,926 (430,961) 1,597,953 (3,766,208)
Net loss $ (627,046) $ (4,649,192) $ (2,774,014) $ (12,216,446)
Net loss per share - basic and diluted (in dollars per share) $ (0.04) $ (0.39) $ (0.18) $ (1.06)
Weighted average common shares outstanding - basic and diluted (in shares) 15,144,243 11,906,334 15,130,666 11,525,730
Comprehensive loss:        
Net loss $ (627,046) $ (4,649,192) $ (2,774,014) $ (12,216,446)
Foreign currency translation adjustment (1,604) (384) (1,489) (555)
Comprehensive loss $ (628,650) $ (4,649,576) $ (2,775,503) $ (12,217,001)

Source